-

fact sheet

PhRMA Comment: Draft Guidance for Industry and Review Staff: Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities

The Pharmaceutical Research and Manufacturers of America's comments in response to FDA’s Draft Guidance for Industry and Review Staff entitled “Drug and Device Manufacturer Communications With Payors, Formulary Committees, and Similar Entities/Questions and Answers”. – Questions and Answers, Docket No. FDA–2016–D–1307, 82 Fed. Reg. 6568 (Jan. 19, 2017)